CASEY NELSON: Open Payments
NPI 1790827251 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 87 payments from 12 companies in 2025. Trend: 2023 $991 · 2024 $2,450 · 2025 $2,023
Food & beverage: $1,943Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $541 |
| GENZYME CORPORATION | 14 | $343 |
| ABBVIE INC. | 16 | $315 |
| UCB, Inc. | 12 | $287 |
| Lilly USA, LLC | 6 | $134 |
| Amgen Inc. | 4 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $86 |
| Arcutis Biotherapeutics, Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $45 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, TALTZ, OTEZLA, RINVOQ, Zoryve.
Industry payments across UT — which companies pay providers there.
